Smoking and the Older Person

Citation: 

Pages 20 - 24

Authors: 

Ehab E. Tuppo, DO, MS

Since the first Surgeon General report on smoking was issued in 1964, the smoking rate in the United States has been progressively declining.1 Yet today, cigarette smoking remains the leading cause of preventable death in the United States, and it is associated with significant health and economic burdens to society.2 A vast array of resources have been assigned to address smoking cessation or abstinence programs, almost exclusively aimed at the adult and adolescent populations. Little to no attention has been paid to older smokers. Obstacles to smoking intervention in the elderly include the beliefs that little or nothing can be done to change the habits of older individuals,3 there is little health benefit from smoking cessation, and it is one of the few pleasures in life left to older persons. This article reviews current literature about the harmful effects of smoking in the elderly and the benefits of smoking cessation among this growing population.

EPIDEMIOLOGY OF AGING AND SMOKING
Older adults 65 years of age and older are the fastest growing segment of the population in the United States, totaling almost 40 million and making up more than 12% of the population.4 It is projected that their number will grow to more than 71 million and will account for close to 20% of the total population by the year 2030.5

Although smoking rates continue to decline for the adult population at large, and for the elderly population in particular, approximately 440,000 people continue to die yearly in the United States from illnesses attributable to cigarette smoking.2 Only 9.3% of adults 65 years of age and older smoke, but it is more worrisome that 21.8% of adults 45-64 years of age are current smokers. It is this large smoking population that will be of major concern to the health care system in the near future.6 Programs geared toward the elderly will be necessary to reduce the number of smokers in the present elderly age group and the soon-to-be elderly age group.

TOBACCO CHEMICALS AND CARCINOGENS
At least 4000 chemicals and 60 carcinogens have been identified in tobacco smoke.7,8 These carcinogens include aromatic amines, phenols, nitrogen dioxide compounds, aldehydes, polycyclic aromatic hydrocarbons, nitrosamines, volatile hydrocarbons, inorganic compounds, and other organic compounds. These chemicals have been shown to be carcinogenic in human and animal models. The list does not exclude the presence of other carcinogens that have yet to be identified or evaluated.

The mechanism by which smoking carcinogens cause cancer is believed to be via the production of DNA adducts.9 DNA adducts are formed by covalent bonds between the carcinogen and the DNA and can disturb the architecture of the DNA. DNA adducts are implicated in many types of human cancers, and they can block antitumor genes and activate oncogenes. Another mechanism proposed for the damage induced by smoking is via the production of free radicals. Products of free radical–induced lipid peroxidation were shown to be significantly elevated in smokers as compared to nonsmokers.10,11 Evidence of free radical damage is not only limited to lipid peroxidation, because smoking has also been shown to induce oxidative damage of proteins and DNA.12,13 Interestingly, there is evidence suggesting that smoking causes significantly greater free radical–induced damage in older smokers than in young adult smokers, implying that the elderly are more susceptible to the hazards of smoking (E. E. Tuppo, DO, unpublished data, July 2005).

References: 

REFERENCES
1. Centers for Disease Control and Prevention. Cigarette smoking among adults-United States, 2001. MMWR 2003;52(4):953-956.

2. Centers for Disease Control and Prevention. Annual smoking-attributable mortality, years of potential life lost, and economic costs—United States, 1995-1999. MMWR 2002;51:300-303.

3. Appel DW, Aldrich TK. Smoking cessation in the elderly. Clin Geriatr Med 2003;19(1):77-100.

4. Population Division, U.S. Census Bureau. Annual estimates of the civilian population by selected age groups for the United States and States: July 1, 2003 and July 1, 2000. Available at: http: //www.census.gov/popest/states/tables/ST-EST2003-01civ.pdf. Accessed July 8, 2005.

5. U.S. Census Bureau. Projected population of the United States by age and sex: 2000 to 2050. Available at: http: //www.census. gov/ipc/www/usinterimproj/. Accessed July 8, 2005.

6. Centers for Disease Control and Prevention. Prevalence of current smoking among adults aged 18 years and older: United States, 1997-2003. Available at: http: //www.cdc.gov/nchs/data/nhis/earlyrelease/200312_08.pdf. Accessed July 8, 2005.

7. Hecht SS. Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat Rev Cancer 2003;3:733-744.

8. Hecht SS. Cigarette smoking and lung cancer: Chemical mechanisms and approaches to prevention. Lancet Oncol 2002;3:461-469.

9. Hecht SS. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 1999;91(14): 1194-1210.

10. Morrow JD, Frei B, Longmire AW, et al. Increase in circulating products of lipid peroxidation (F2 isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med 1995;332 (18):1198-1203.

11. Reilly M, Delanty N, Lawson JA, FitzGerald GA. Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation 1996;94:19-25.

12. Panda K, Chattopadhyay R, Chattopadhyay DJ, Chatterjee IB. Vitamin C prevents cigarette smoke-induced oxidative damage in vivo. Free Radic Biol Med 2000;29(2):115-124.

13. Lee BM, Lee SK, Kim HS. Inhibition of oxidative DNA damage, 8-OHdG, and carbonyl contents in smokers treated with antioxidants (vitamin E, vitamin C, beta-carotene and red Ginseng). Cancer Lett 1998;132:219-227.

14. Burns DM. Cigarette smoking among the elderly: Disease consequences and the benefits of cessation. Am J Health Promot 2000;14(6):357-361.

15. Vetter NJ. The impact of smoking in elderly people. Rev Clin Gerontol 1999;9(3): 273-280.

16. Fincham JE. The etiology and pathogenesis of detrimental health effects in elderly smokers. J Geriatric Drug Ther 1992;7(1):5-21.

17. Thun M, Myers D, Day-Lally C, et al. Age and the exposure-response relationships between cigarette smoking and premature death in Cancer Prevention Study II. In: Burns DM, Garfinkel L, Samet JM, eds. National Cancer Institute, Smoking and Tobacco Control, Monograph 8: Changes in cigarette-related disease risks and their implication for prevention and control. NIH publication 97-4213. Bethesda, MD: National Cancer Institute, National Institutes of Health; 1997:383-476.

18. LaCroix AZ, Lang J, Scherr P, et al. Smoking and mortality among older men and women in three communities. N EnglJ Med 1991;324(23):1619-1625.

19. Henschke CI, Miettinen OS. Women’s susceptibility to tobacco carcinogens. Lung Cancer 2004;43:1-5.

20. Zevin S, Benowitz NL. Drug interactions with tobacco smoking. An update. Clin Pharmacokinet 1999;36(6):425-438.

21. Maxwell CJ, Hirdes JP. The prevalence of smoking and implications for quality of life among the community-based elderly. Am J Prev Med 1993;9(6):338-345.

22. Williams CD, Lewis-Jack O, Johnson K, Adams-Campbell L. Environmental influences, employment status, and religious activity predict current cigarette smoking in the elderly. Addict Behav 2001;26:297-301.

23. Nordstrom BL, Kinnunen T, Utman CH, et al. Predictors of continued smoking over 25 years of follow-up in the normative study aging study. Am J Publ Health 2000;90(3):404-406.

24. Oei TP, Tilley D, Gow K. Differences in reasons for smoking between younger and older smokers. Drug Alcohol Rev 1991;10:323-330.

25. Department of Health and Human Services. The health benefits of smoking cessation: A report of the Surgeon General. DHHS No. CDC 90-8416. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 1990.

26. Halpern MT, Gillespie BW, Warner KE. Patterns of absolute risk of lung cancer mortality in former smokers. J Natl Canc Inst 1993;85(6):457-464.

27. Hermanson B, Omenn GS, Kronmal RA, Gersh BJ. Beneficial six-year outcome of smoking cessation in older men and women with coronary artery disease. Results from the CASS registry. N Engl J Med 1988;319(21):1365-1369.

28. Bronnum-Hansen H, Juel K. Abstention from smoking extends life and compresses morbidity: A population based study of health expectancy among smokers and never smokers in Denmark. Tob Control 2001;10(3):273-278.

29. Nusselder WJ, Looman CW, Marang-van de Mheen PJ, et al. Smoking and the compression of morbidity. J Epidemiol Community Health 2000;54(8):566-574.

30. McIlvain HE, Crabtree BF, Backer EL, Turner PD. Use of office-based smoking cessation activities in family practices. J Fam Pract 2000;49(11):1025-1029.

31. Goldstein MG, DePue JD, Monroe AD, et al. A population-based survey of physician smoking cessation counseling practices. Prev Med 1998;27(5 Pt 1):720-729.

32. Goldstein MG, Niaura R, Willey-Lessne C, et al. Physicians counseling smokers: A population-based survey of patients’ perceptions of health care provider-delivered smoking cessation interventions. Arch Intern Med 1997;157:1313-1319.

33. Jaen CR, McIlvain H, Pol L, et al. Tailoring tobacco counseling to the competing demands in the clinical encounter. J Fam Pract 2001;50(10):859-863.

34. Denny CH, Serdula MK, Holtzman D, Nelson DE. Physician advice about smoking and drinking: Are U.S. adults being informed? Am J Prev Med 2003;24(1):71-74.

35. Brown DW, Croft JB, Schenck AP, et al. Inpatient smoking-cessation counseling and all-cause mortality among the elderly. Am J Prev Med 2004;26(2):112-118.

36. Doescher MP, Saver BG. Physicians’ advice to quit smoking. The glass remains half empty. J Fam Pract 2000;49(6):543-547.

37. Maguire CP, Ryan J, Kelly A, et al. Do patient age and medical condition influence medical advice to stop smoking? Age Ageing 2000;29:264-266.

38. Dale LC, Olsen DA, Patten CA, et al. Predictors of smoking cessation among elderly smokers treated for nicotine dependence. Tob Control 1997;6:181-187.

39. Kaplan MS, Newsom JT, McFarland BH. Older adults’ contact with health practitioners: Is there an association with smoking practices? J Gerontol A Biol Sci Med Sci 2002;57(6):M343-M346.

40. Morgan GD, Noll EL, Orleans CT, et al. Reaching midlife and older smokers: Tailored interventions for routine medical care. Prev Med 1996;25:346-354.

41. Rimer BK, Orleans CT, Fleisher L, et al. Does tailoring matter? The impact of a tailored guide on ratings and short-term smoking-related outcomes for older smokers. Health Educ Res 1994;9(1):69-84.

42. Rimer BK, Orleans CT. Tailoring smoking cessation for older adults. Cancer 1994;74(7 Suppl):2051-2054.

43. Gourlay SG, Benowitz NL. The benefits of stopping smoking and the role of nicotine replacement therapy in older patients. Drugs Aging 1996;9(1):8-23.